Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Retatrutide (development code LY3437943) is a 39-amino acid synthetic peptide developed by Eli Lilly as the first triple-receptor agonist targeting GLP-1R, GIPR, and GCGR in a single molecule
What GLP-1 Side Effects Did Redditors Report
This mechanism explains why some people on retatrutide never feel truly hungry but also never feel truly energized
Retatrutide is administered subcutaneously, meaning into the fat layer just beneath the skin
Its job
Injection site reactions are more common with Bydureon due to the long-acting formulation
US$ 23.71
US$ 21.46
US$ 23.08
US$ 27.76
US$ 27.85
US$ 20.15
US$ 23.67
US$ 22.79
US$ 26.39
US$ 23.15
US$ 25.48
US$ 26.59
